Notícias e Atividades da Passage Bio

Passage Bio é uma empresa listada sob o símbolo PASG (US).

Fusão, aquisição e financiamento envolvendo Passage Bio.

• Passage Bio and Remix Therapeutics have announced they will merge  (publicado em 25 de junho de 2026)..

Veja o organograma con seus 19 executivos principais

Biografias mais buscadas da Passage Bio

• William Chou, Chief Executive Officer and Director
• Derrell Porter, Director
• Saqib Islam, Director

Recentes movimentos de executivos em Passage Bio

• Justin Poley, Executive Director, Manufacturing Operations, deixou a Companhia  (Notícia publicada em 22 de junho de 2026).

Criar um alerta
para seguir os movimentos de executivos da Passage Bio.

Passage Bio possui 2.428 concorrentes concorrentes Lonza (Suíça), Vertex Pharmaceuticals (Estados Unidos) e Eurofins (Luxemburgo).

Popular M&A news in Biotecnologia

• Eli Lilly has announced the acquisition of AtaiBeckley  (publicado em 17 de julho de 2026).
• GSK adquiriu Nuvalent (publicado em 17 de julho de 2026).
• Clearside Biomedical has gone out of its bankruptcy protection  (publicado em 15 de julho de 2026).

Outros contatos sugeridos na indústria do Biotecnologia

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer da Inceptive
• Jan Van de Winkel - President and Chief Executive Officer da Genmab
• Robert Gould - Board Member da Fulcrum Therapeutics

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Passage Bio

• Events & Presentations - Passage BIO, Inc.
• Passage Bio Announces Publication of Preclinical Data That Show Single Injection of Optimized AAV Vector into Cerebral Spinal Fluid Corrects Neurological Disease, Supporting Advancement of PBGM01 into Clinic - Passage BIO, Inc.
• Press Releases - Passage BIO, Inc.
• Passage Bio to Participate in 2020 Virtual Cell & Gene Meeting on the Mesa - Passage BIO, Inc.
• Passage Bio to Participate in Upcoming October Investor Conferences - Passage BIO, Inc.
• Passage Bio Announces Publication of Preclinical Gene Therapy Study Data from Frontotemporal Dementia Program - Passage BIO, Inc.
• Passage Bio to Participate in Citi’s 15th Annual BioPharma Virtual Conference - Passage BIO, Inc.
• Passage Bio Reports Second Quarter 2020 Financial Results and Recent Business Highlights - Passage BIO, Inc.
• Passage Bio to Report Second Quarter 2020 Financial Results on August 13, 2020 - Passage BIO, Inc.
• Passage Bio Added to Russell 2000 Index - Passage BIO, Inc.
• View more press releases Close

Redes sociais sobre Passage Bio

• Passage Bio na Wikipedia, Google News e Yahoo Finance
• Passage Bio na LinkedIn, X (Twitter) e YouTube